111, Inc. (YI)

USD 8.4

(1.82%)

Total Liabilities Summary of 111, Inc.

111, Inc.'s latest annual total liabilities in 2023 was 2.81 Billion CNY , down -0.45% from previous year.
111, Inc.'s latest quarterly total liabilities in 2024 Q2 was 2.54 Billion CNY , down -3.88% from previous quarter.
111, Inc. reported annual total liabilities of 2.82 Billion CNY in 2022, up 23.0% from previous year.
111, Inc. reported annual total liabilities of 2.29 Billion CNY in 2021, up 35.46% from previous year.
111, Inc. reported quarterly total liabilities of 2.64 Billion CNY for 2024 Q1, down -5.96% from previous quarter.
111, Inc. reported quarterly total liabilities of 3.04 Billion CNY for 2023 Q3, up 26.41% from previous quarter.

Annual Total Liabilities Chart of 111, Inc. (2023 - 2016)

Historical Annual Total Liabilities of 111, Inc. (2023 - 2016)

Year	Total Liabilities	Total Liabilities Growth
2023	2.81 Billion CNY	-0.45%
2022	2.82 Billion CNY	23.0%
2021	2.29 Billion CNY	35.46%
2020	1.69 Billion CNY	102.76%
2019	836.37 Million CNY	159.22%
2018	322.65 Million CNY	-27.42%
2017	444.56 Million CNY	21.44%
2016	366.08 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	2.54 Billion CNY	-3.88%
2024 Q1	2.64 Billion CNY	-5.96%
2023 Q3	3.04 Billion CNY	26.41%
2023 FY	2.81 Billion CNY	-0.45%
2023 Q1	2.58 Billion CNY	-8.43%
2023 Q4	2.81 Billion CNY	-7.64%
2023 Q2	2.4 Billion CNY	-6.87%
2022 Q1	2.23 Billion CNY	-2.72%
2022 Q4	2.82 Billion CNY	19.07%
2022 FY	2.82 Billion CNY	23.0%
2022 Q2	2.37 Billion CNY	6.39%
2022 Q3	2.37 Billion CNY	-0.18%
2021 Q4	2.29 Billion CNY	4.41%
2021 FY	2.29 Billion CNY	35.46%
2021 Q3	2.19 Billion CNY	-1.95%
2021 Q2	2.24 Billion CNY	19.51%
2021 Q1	1.87 Billion CNY	10.72%
2020 Q4	1.69 Billion CNY	-7.1%
2020 Q2	1.29 Billion CNY	32.21%
2020 FY	1.69 Billion CNY	102.76%
2020 Q1	979.05 Million CNY	17.06%
2020 Q3	1.82 Billion CNY	41.02%
2019 Q3	731.31 Million CNY	4.05%
2019 Q2	702.87 Million CNY	38.33%
2019 Q1	508.1 Million CNY	57.48%
2019 Q4	836.37 Million CNY	14.37%
2019 FY	836.37 Million CNY	159.22%
2018 Q2	341.54 Million CNY	35.64%
2018 FY	322.65 Million CNY	-27.42%
2018 Q4	322.65 Million CNY	-10.25%
2018 Q1	251.79 Million CNY	-43.36%
2018 Q3	359.49 Million CNY	5.26%
2017 FY	444.56 Million CNY	21.44%
2017 Q1	- CNY	0.0%
2017 Q4	444.56 Million CNY	0.0%
2016 FY	366.08 Million CNY	0.0%

Peer Total Liabilities Comparison of 111, Inc.

Name	Total Liabilities	Total Liabilities Difference
CannBioRx Life Sciences Corp.	5.38 Million USD	-52115.015%
China Jo-Jo Drugstores, Inc.	80.76 Million USD	-3382.905%
Harrow Health, Inc. 8.625% Senior Notes due 2026	241.75 Million USD	-1063.556%
Harrow Health, Inc. 11.875% Senior Notes due 2027	241.75 Million USD	-1063.556%
Leafly Holdings, Inc.	34.29 Million USD	-8102.642%
LifeMD, Inc.	52.91 Million USD	-5215.99%
LifeMD, Inc.	52.91 Million USD	-5215.99%
TRxADE HEALTH, Inc.	11.99 Million USD	-23359.555%
PetMed Express, Inc.	78.36 Million USD	-3489.663%
Walgreens Boots Alliance, Inc.	68.85 Billion USD	95.915%